NEUTRON Therapy operates as a hybrid treatment by alternating between Frequency-Specific Microcurrent (FSM) and Nanoampere-Range Current Stimulation (nA-Range Stimulation) within 40 to 120 Hz. Rather than combining them simultaneously, it cycles between the two current types, allowing each to engage tissues through its mechanism. The frequency range remains consistent, while amplitude and waveform shift between phases.

When the nA-Range Stimulation phase is active, the device outputs current in the nanoampere range (billionths of an ampere). At this low amplitude, the current does not override cellular activity but instead subtly interacts with the body’s bioelectric environment. It may influence voltage-gated ion channels and support the restoration of a normal resting membrane potential across cell membranes, helping to establish a stable baseline.

When the sequence switches to the FSM phase, the amplitude increases to the microampere range (millionths of an ampere). Within the same frequency window, selected frequencies are delivered to support particular tissues and conditions. At this amplitude, the current may provide metabolic support
by enhancing ATP production, while the frequency component may create a resonant interaction with cellular structures. This resonance is thought to influence intracellular signalling pathways and ion exchange mechanisms across the body.

The alternating pattern is mechanistically significant. nA-Range Stimulation supports membrane stability and cellular readiness, while FSM delivers targeted resonant input. As these phases rotate, the body experiences a rhythmic interplay of normalisation and focused stimulation. This may reduce cellular accommodation to a single stimulus and allow tissues such as nerves, muscles, connective tissue and organs to respond according to their own resonant properties. The result is a unified, system-wide engagement that supports the body’s intrinsic regulatory processes without imposing a single directional force.